EDGAR Filing Documents for 0001654954-17-009085

Form S-8 - Securities to be offered to employees in employee benefit plans:

SEC Accession No. 0001654954-17-009085

Filing Date

2017-10-03

Accepted

2017-10-03 16:10:13

Documents

Effectiveness Date

2017-10-03

Document Format Files

Seq	Description	Document	Type	Size
1	REGISTRATION STATEMENT ON FORM S-8	azrx_s8.htm	S-8	93419
2	OPINION ON LEGALITY	ex5-1.htm	EX-5.1	11332
3	CONSENT OF MAZARS USA LLP	ex23-1.htm	EX-23.1	3827
	Complete submission text file	0001654954-17-009085.txt		109661

Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226

Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855

AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: S-8 | Act: 33 | File No.: 333-220781 | Film No.: 171117920
SIC: 2834 Pharmaceutical Preparations